Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanguard Mid-Cap Growth Index Fund ETF Shares (VOT)

Delayed Data
As of 2:08pm ET
 -0.07 / -0.05%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the performance of the CRSP US Mid Cap Growth Index that measures the investment return of mid-capitalization growth stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Mid Cap Growth Index- a broadly diversified index of growth stocks of mid-size U.S. companies. The advisor attempts to replicate the target index by investing all- or substantially all- of its assets in the stocks that make up the index- holding each stock in approximately the same proportion as its weighting in the index.

No recent news for Vanguard Mid-Cap Growth Index Fund ETF Shares.


1 month+1.69% 3 years+8.40%
3 months+5.70% 5 years+14.38%
1 year+19.16% Since inception+8.98%
Data through 12/08/2017

Quote Details

Previous close$127.32
Open day’s range127.14 – 127.55
Net asset value (NAV)126.71 (12/07/2017)
Daily volume56,120
Average volume (3 months)96,082
Data as of 2:08pm ET, 12/11/2017

Peer Comparisonvs. Mid-cap growth ETFs

Performance 5-yr return+14.38%+12.62%
Expense Gross exp ratio0.07%1.22%
Risk 5 year sharpe ratio1.291.18
Net assets$11.3B$1.5B
Average market cap$14.6B$12.1B
Average P/E29.429.4
Dividend / Share--0.09%


IWP iShares Russell Mid-Cap Growth ETF
IVOG Vanguard S&P Mid-Cap 400 Growth Index Fu...
MDYG SPDR® S&P 400 Mid Cap Growth ETF


Top 5 Sectors
Portfolio weighting
Industrial materials 14.84%
Healthcare 13.70%
Energy 13.03%
Consumer service 12.95%
Hardware 9.64%
Top 10 Holdings
Portfolio weighting
LRCX Lam Research Corp1.97%
ADSK Autodesk Inc1.60%
FISV Fiserv Inc1.58%
APH Amphenol Corp1.55%
ROP Roper Technologies Inc1.54%
DLR Digital Realty Trust Inc1.41%
BCR C R Bard Inc1.38%
MCO Moody's Corp1.35%
MCHP Microchip Technology Inc1.28%
EW Edwards Lifesciences Corp1.26%